US Stock MarketDetailed Quotes
COGT Cogent Biosciences
- 6.020
- +0.010+0.17%
Close Apr 26 16:00 ET
- 5.900
- -0.120-1.99%
Post 17:04 ET
575.59MMarket Cap-2487P/E (TTM)
6.160High5.945Low912.17KVolume6.020Open6.010Pre Close5.49MTurnover1.34%Turnover RatioLossP/E (Static)95.61MShares13.50052wk High2.91P/B408.59MFloat Cap3.67052wk Low--Dividend TTM67.87MShs Float174.200Historical High--Div YieldTTM3.58%Amplitude1.904Historical Low6.016Avg Price1Lot Size
Cogent Biosciences Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -29.49%-153.62M | -49.86%-44.07M | -10.25%-37.97M | -21.21%-32.07M | -39.47%-39.52M | -101.89%-118.64M | -41.54%-29.41M | -144.10%-34.44M | -111.46%-26.46M | -149.29%-28.33M |
| Net income from continuing operations | -37.20%-192.41M | -37.22%-54.37M | -57.95%-55.38M | -26.19%-44.08M | -25.96%-38.59M | -94.04%-140.24M | -59.03%-39.62M | -83.72%-35.06M | -111.05%-34.93M | -161.20%-30.63M |
| Operating gains losses | --8K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -38.96%3.59M | -15.26%794K | -76.96%855K | 81.49%1.22M | 29.11%723K | 195.23%5.88M | 71.61%937K | 621.98%3.71M | -26.70%670K | 3,194.12%560K |
| Other non cash items | -25.00%-1.7M | --0 | --0 | --0 | ---1.7M | -296.50%-1.36M | ---- | ---- | ---- | ---- |
| Change In working capital | 1,423.57%11.44M | -27.06%4.94M | 200.45%6.89M | 33.70%4.37M | -95.48%-4.76M | 326.70%751K | 2,677.19%6.78M | -787.27%-6.86M | 511.80%3.27M | -122.78%-2.44M |
| -Change in prepaid assets | 57.87%-626K | 13.35%1.85M | 18.91%-1.79M | -114.53%-369K | 57.12%-316K | -554.63%-1.49M | -2.04%1.63M | -61.20%-2.21M | 91.02%-172K | -152.95%-737K |
| -Change in payables and accrued expense | 8.69%12.98M | -38.51%3.42M | 179.12%8.96M | 97.39%4.84M | -678.25%-4.23M | 93.22%11.95M | 1,770.03%5.55M | 8.45%3.21M | -54.37%2.45M | 129.89%731K |
| -Change in other current assets | 88.31%-119K | -108.70%-2K | -168.50%-87K | --0 | 98.40%-30K | 72.69%-1.02M | 101.36%23K | 292.42%127K | 129.43%711K | -521.30%-1.88M |
| -Change in other current liabilities | 90.84%-796K | 25.93%-320K | 97.65%-188K | -136.46%-101K | 66.00%-187K | -323.49%-8.69M | 19.40%-432K | -1,423.85%-7.99M | 154.64%277K | -13.40%-550K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -29.49%-153.62M | -49.86%-44.07M | -10.25%-37.97M | -21.21%-32.07M | -39.47%-39.52M | -101.89%-118.64M | -41.54%-29.41M | -144.10%-34.44M | -111.46%-26.46M | -149.29%-28.33M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 21.56%-97.82M | -63.08%10.49M | 40.26%-90.54M | -6,688.55%-77.66M | 13,679.14%59.88M | -7,155.26%-124.72M | 6,661.43%28.41M | -12,930.44%-151.54M | -830.08%-1.14M | -441K |
| Net PPE purchase and sale | 59.26%-2.8M | 83.99%-315K | 96.35%-121K | -9.88%-1.26M | -150.11%-1.1M | -299.24%-6.86M | -354.27%-1.97M | -184.69%-3.31M | -830.08%-1.14M | ---441K |
| Net investment purchase and sale | 19.37%-95.03M | -64.43%10.8M | 39.00%-90.42M | ---76.4M | --60.99M | ---117.86M | --30.38M | ---148.23M | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 21.56%-97.82M | -63.08%10.49M | 40.26%-90.54M | -6,688.55%-77.66M | 13,679.14%59.88M | -7,155.26%-124.72M | 6,661.43%28.41M | -12,930.44%-151.54M | -830.08%-1.14M | ---441K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -0.01%163.54M | 0 | 1.01%1M | -0.01%162.09M | 222.46%445K | 330.69%163.56M | -99.17%315K | 1,700.00%990K | 162.12M | 262.35%138K |
| Net common stock issuance | -0.08%161.82M | --0 | 0.00%-170K | ---- | ---- | 326.10%161.95M | --0 | ---170K | ---- | ---- |
| Proceeds from stock option exercised by employees | 6.45%1.72M | --0 | 0.86%1.17M | --102K | 222.46%445K | 2,832.73%1.61M | --315K | 2,009.09%1.16M | --0 | --138K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -0.01%163.54M | --0 | 1.01%1M | -0.01%162.09M | 222.46%445K | 330.69%163.56M | -99.17%315K | 1,700.00%990K | --162.12M | 262.35%138K |
| Net cash flow | ||||||||||
| Beginning cash position | -36.12%141.14M | -38.79%86.81M | -34.42%214.32M | -15.78%161.95M | -36.12%141.14M | -9.24%220.94M | -30.53%141.82M | 48.99%326.82M | -17.11%192.3M | -9.24%220.94M |
| Current changes in cash | -10.17%-87.91M | -4,823.90%-33.58M | 31.08%-127.51M | -61.07%52.36M | 172.68%20.81M | -254.56%-79.8M | -104.06%-682K | -1,115.71%-184.99M | 1,164.71%134.52M | -150.08%-28.64M |
| End cash Position | -62.29%53.23M | -62.29%53.23M | -38.79%86.81M | -34.42%214.32M | -15.78%161.95M | -36.12%141.14M | -36.12%141.14M | -30.53%141.82M | 48.99%326.82M | -17.11%192.3M |
| Free cash flow | -24.64%-156.42M | -41.47%-44.39M | -0.90%-38.09M | -20.74%-33.32M | -41.16%-40.62M | -107.50%-125.5M | -47.93%-31.38M | -147.19%-37.75M | -118.46%-27.6M | -153.17%-28.78M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg